Sustained response of refractory prolymphocytic leukemia to fludarabine.

Abstract

A patient with de novo prolymphocytic leukemia who was refractory to chemotherapy and splenic radiation achieved a dramatic sustained response following 3 courses of therapy with fludarabine.

• Authors: J R Sporn
• Journal: Acta haematologica (Acta Haematol) Vol. 85 Issue 4 Pg. 209-11 ( 1991) ISSN: 0001-5792 [Print] Switzerland
• PMID: 1853684 (Publication Type: Case Reports, Journal Article)

Chemical References

• Antimetabolites, Antineoplastic
• Vidarabine
• fludarabine

Topics

• Aged
• Antimetabolites, Antineoplastic (administration & dosage, therapeutic use)
• Humans
• Leukemia, Prolymphocytic (blood, drug therapy, pathology)
• Leukocyte Count
• Male
• Remission Induction
• Spleen (pathology)
• Vidarabine (administration & dosage, analogs & derivatives, therapeutic use)